MAYOSAFE FORTE SOFTGEL CAPSULES

Product Description

MAYOSAFE FORTE SOFTGEL CAPSULES, powered by Bupropion 150mg, is a well-tolerated, prescription-grade medication widely used for smoking cessation support and depression management. This extended-release formula offers enhanced bioavailability and consistent therapeutic effects, making it a dependable choice for healthcare professionals.

Formulated with high standards and manufactured in WHO-GMP certified facilities, MAYOSAFE FORTE is ideal for bulk procurement by pharmaceutical distributors, hospital pharmacies, and B2B healthcare buyers seeking a clinically trusted, fast-moving product in the neuropsychiatry segment.

Key Benefits:

• Contains Bupropion 150mg effective in treating major depressive disorder (MDD) and nicotine addiction

• Non-sedative and well-suited for long-term use

• Enhanced patient adherence with softgel capsule format

• Manufactured with international quality standards

Primary Applications:

• Smoking cessation aid

• Treatment of clinical depression and seasonal affective disorder (SAD)

• Used in mental health clinics and neuro care centers

Why Distributors Choose MAYOSAFE FORTE:

• High demand neuropsychiatric product with proven market traction

• Attractive margins for B2B resellers and exporters

• Available in bulk packs for hospitals, clinics, and online pharmacies